MedPath

sing a test called QEEG i.e. quantitative electroencephalogram to check the response to clozapine in patients of schizophrenia with no response on multiple medications previously.

Phase 4
Conditions
Health Condition 1: F20- Schizophrenia
Registration Number
CTRI/2023/09/058046
Lead Sponsor
Government medical college and hospital sector 32
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Diagnosis of schizophrenia according to ICD-11.24

2. Established as Treatment resistant schizophrenia as per Treatment response and resistance

in psychosis (TRIPP) working group consensus guidelines3

3. Patients who have not received clozapine in the past.

Exclusion Criteria

1. Patients with co-morbid substance dependence (except nicotine and caffeine)

2. Patients with history of severe cardiac or renal disorders, or a history of neutropenia,

bone-marrow disorders, paralytic ileus, acute substance-induced psychosis or

intoxication, circulatory collapse or epilepsy.

3. Patients on any depot I/M drug preparation.

4. Patients who have received ECT in past 2 weeks.

5. Patients who are lactating or pregnant.

6. Patient with any neurological disorders.

7. Patients with history of seizure in past.

8. Patients on any immunosuppressant.

9. Acutely suicidal patients.

10. Acutely violent patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath